These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 14615910)
21. BCR/ABL rearrangement with b3a3 fusion transcript in a case of childhood acute lymphoblastic leukemia. Kim J; Park TS; Lyu CJ; Song J; Lee KA; Kim SJ; Lee HJ; Choi JR Cancer Genet Cytogenet; 2009 Mar; 189(2):132-7. PubMed ID: 19215796 [TBL] [Abstract][Full Text] [Related]
22. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion. Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603 [TBL] [Abstract][Full Text] [Related]
23. Generation of the BCR/ABL fusion gene in a Philadelphia chromosome-negative chronic myeloid leukaemia: insertion of 5.6 Mb of 9q34 into the BCR region of chromosome 22. Valle L; Fernández V; Pérez-Pons C; Sánchez FG; Benítez J; Urioste M Hematol Oncol; 2006 Jun; 24(2):86-8. PubMed ID: 16598834 [TBL] [Abstract][Full Text] [Related]
24. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG). Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310 [TBL] [Abstract][Full Text] [Related]
25. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia. Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907 [TBL] [Abstract][Full Text] [Related]
26. 9q34 rearrangements in BCR/ABL fusion-negative acute lymphoblastic leukemia. Dave BJ; Wiggins M; Higgins CM; Pickering DL; Perry D; Aoun P; Abromowich M; DeVetten M; Sanger WG Cancer Genet Cytogenet; 2005 Oct; 162(1):30-7. PubMed ID: 16157197 [TBL] [Abstract][Full Text] [Related]
27. Successive transformation of chronic myelomonocytic leukaemia into acute myeloblastic then lymphoblastic leukaemia, both with minor-bcr rearrangement. Dautel MM; François S; Bertheas MF; Baranger L; Gardais J; Boasson M; Ifrah N; Blanchet O Br J Haematol; 1997 Jul; 98(1):210-2. PubMed ID: 9233586 [TBL] [Abstract][Full Text] [Related]
28. Philadelphia chromosome positive B-cell type malignant lymphoma expressing an aberrant 190 kDa bcr-abl protein. Mitani K; Sato Y; Tojo A; Ishikawa F; Kobayashi Y; Miura Y; Miyazono K; Urabe A; Takaku F Br J Haematol; 1990 Oct; 76(2):221-5. PubMed ID: 2094324 [TBL] [Abstract][Full Text] [Related]
29. Molecular and phenotypic analysis of Philadelphia chromosome-positive bilineage leukemia: possibility of a lineage switch from T-lymphoid leukemic progenitor to myeloid cells. Monma F; Nishii K; Ezuki S; Miyazaki T; Yamamori S; Usui E; Sugimoto Y; Lorenzo V F; Katayama N; Shiku H Cancer Genet Cytogenet; 2006 Jan; 164(2):118-21. PubMed ID: 16434313 [TBL] [Abstract][Full Text] [Related]
30. Fluorescence in situ hybridization dissection of a chronic myeloid leukemia case bearing the apparently balanced translocations (9;22)(q34;q11.2) and (11;11)(p15;q13). Malvestiti F; Colombo D; Perego D; Rodeschini O; Finelli P; Larizza L; Giardino D Cancer Genet Cytogenet; 2009 Jan; 188(1):42-7. PubMed ID: 19061779 [TBL] [Abstract][Full Text] [Related]
31. A masked BCR/ABL rearrangement in a case of chronic myeloid leukemia with translocation t(3;9)(p14;q34). Bennour A; Sennana H; Laatiri MA; Khelif A; Saad A Cancer Genet Cytogenet; 2008 Feb; 181(1):72-4. PubMed ID: 18262060 [No Abstract] [Full Text] [Related]
32. [Myelodysplastic syndrome in a child which developed into megakaryocytic leukemia with late appearing Ph1 chromosome and rearrangement of breakpoint cluster region]. Inaba T; Hayashi Y; Hosoya S; Hanada R; Yamamoto K; Nishida T; Nakamura K; Mizutani S; Sugita K; Nakazawa S Rinsho Ketsueki; 1990 Jul; 31(7):994-8. PubMed ID: 2214196 [TBL] [Abstract][Full Text] [Related]
33. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia]. Matolcsy A Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695 [TBL] [Abstract][Full Text] [Related]
34. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia. Foroni L; Gerrard G; Nna E; Khorashad JS; Stevens D; Swale B; Milojkovic D; Reid A; Goldman J; Marin D Am J Hematol; 2009 Aug; 84(8):517-22. PubMed ID: 19544476 [TBL] [Abstract][Full Text] [Related]
35. Novel t(8;17)(q23;q24.2) and t(9;22)(p24.1;q12.2) in acute megakaryoblastic leukemia AML-M7 subtype in an adult patient. Ahmad F; Dalvi R; Das BR; Mandava S Cancer Genet Cytogenet; 2009 Sep; 193(2):112-5. PubMed ID: 19665073 [TBL] [Abstract][Full Text] [Related]
36. Megakaryoblastic termination of myeloproliferative disorders. Amin MB; Maeda K; Carey JL; Babu RV; Raman BK Henry Ford Hosp Med J; 1992; 40(1-2):122-6. PubMed ID: 1428963 [TBL] [Abstract][Full Text] [Related]
37. Establishment of a novel human myeloid leukaemia cell line (HNT-34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI1 gene, P210 and P190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome. Hamaguchi H; Suzukawa K; Nagata K; Yamamoto K; Yagasaki F; Morishita K Br J Haematol; 1997 Aug; 98(2):399-407. PubMed ID: 9266939 [TBL] [Abstract][Full Text] [Related]
38. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia. Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536 [TBL] [Abstract][Full Text] [Related]
39. Long-term remission with imatinib mesylate in Philadelphia chromosome-positive AML presenting as primary extramedullary myeloid sarcoma. Ahmed MS; Kroft SH; Davis NB; King DM; Cheng YC Leuk Res; 2008 Sep; 32(9):1476-9. PubMed ID: 18308388 [TBL] [Abstract][Full Text] [Related]
40. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases. Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]